Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-29
1992-10-27
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514452, A61K 3144, A61K 31335
Patent
active
051589567
ABSTRACT:
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 2906757 (1959-09-01), Mills et al.
patent: 2922744 (1960-01-01), Mills et al.
patent: 4794118 (1988-12-01), Kunii et al.
Nelson, W. L. et al., J. Med. Chem., 20, 880-885 (1977).
Gidda Jaswant S.
Schaus John M.
Demeter John C.
Eli Lilly and Company
Waddell Frederick E.
Weddington K.
Whitaker Leroy
LandOfFree
Method of inhibiting gastric acid secretion with benzodioxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting gastric acid secretion with benzodioxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting gastric acid secretion with benzodioxanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905722